A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Clinical trial NCT05991206 · UNKNOWN
Trial details
- NCT number
- NCT05991206
- Sponsor
- Hunan Province Tumor Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-25
- Primary completion
- 2025-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.